SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-05-010206
Filing Date
2005-03-10
Accepted
2005-03-09 18:04:19
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a05-1768_110k.htm 10-K 1593337
2 EX-10.43 a05-1768_1ex10d43.htm EX-10.43 418102
3 EX-10.44 a05-1768_1ex10d44.htm EX-10.44 255012
4 EX-10.45 a05-1768_1ex10d45.htm EX-10.45 471130
5 EX-10.46 a05-1768_1ex10d46.htm EX-10.46 3870
6 EX-23.1 a05-1768_1ex23d1.htm EX-23.1 2667
7 EX-31.1 a05-1768_1ex31d1.htm EX-31.1 11160
8 EX-31.2 a05-1768_1ex31d2.htm EX-31.2 11183
9 EX-32.1 a05-1768_1ex32d1.htm EX-32.1 6938
  Complete submission text file 0001104659-05-010206.txt   2775881
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19700 | Film No.: 05670388
SIC: 2834 Pharmaceutical Preparations